CClinicalTrials.gg
CompletedNCT06115369FOOD-HFUpdated Nov 18, 2025

Food Supplementation Delivered Conditionally vs Not Among Patients With Heart Failure

An interventional study of Medically Tailored Meals Delivered Conditionally and Medically Tailored Meals Delivered Unconditionally in Heart Failure, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-11-18.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The current study proposes to investigate if the provision of healthy food can improve outcomes following discharge after HF hospitalization. To investigate this in an efficient and pragmatic manner, a factorial randomized control trial design will be utilized to simultaneously investigate two separate, important food-related questions:

  • Does the provision of 90 days of either medically-tailored meals or fresh produce boxes improve 90-day patient outcomes among those with HF relative to a control group not receiving food supplements and instead receiving an equivalent monetary supplement?
  • Does receipt of the supplement in a conditional fashion, where the supplement is continued only if the participant attends follow-up visits or fills prescribed medications at the pharmacy, have more impact than providing unconditional supplementation?
Read the detailed description

Eating a nutritious diet is important for maintaining health. However, getting healthy foods can be a challenge for many individuals whose food shopping is limited by finances, location, or physical limitations from pre-existing health problems. For such in-need individuals, providing supplemental healthy meals can improve their diet and potentially improve their health outcomes. Additionally, getting food supplements can also be a powerful incentive to encourage healthy behaviors.

Individuals with heart failure (HF) present a unique population to assess the value of food supplementation both for its nutritional value and as a health engagement incentive. HF is a common, high-cost public health problem in the United States. Hospitalizations for HF are associated with high rates of mortality, readmission, worsened quality of life, and burgeoning healthcare expenditures. During the post-discharge period, patients are exceptionally vulnerable to a wide variety of adverse health events due to multi-system physiologic impairments. Roughly 20% of all patients with Medicare are readmitted within 30 days, and many are readmitted for different causes than the principal diagnosis of the index admission. While multifactorial, frequent contributing causes of HF readmission include dietary indiscretion, failure to take medications, and failure to follow up with healthcare providers.

Prior studies demonstrate that patients with HF often have food insecurity and non-ideal diets. Nationally, food insecurity among those patients with cardiovascular diseases has increased. Those with HF specifically had some of the highest rates of food insecurity, and the prevalence of food insecurity rose from 11.3% in 1999-2000 to 45.3% in 2017-2018.

Studies have also investigated whether providing food supplements to patients with HF can potentially also improve health outcomes. In a recent cohort study, Medicare Advantage patients with acute heart failure (HF) were given up to 4 weeks of post-hospitalization home-delivered meals. Compared with historical controls, those receiving these meals were significantly less likely to have all-cause readmission and death. In contrast, a recent randomized clinical trial found that providing 10 weeks of medically tailored meals to patients with chronic diseases hospitalized during the COVID-19 pandemic did not lead to reductions in risk of 90-day readmission. However, in an exploratory sub-analysis, patients with HF who had the medically tailored meal intervention had significant reductions in readmissions. While these data are supportive of the hypothesis, they are not definitive, and a prospective randomized trial among patients with HF is needed to rigorously support the efficacy of food support in the post-discharge period to reduce readmission. There is also limited information on the type and means of food supplementation may affect its efficacy.

Based on this background, the current study proposes to investigate if the provision of healthy food can improve outcomes following discharge after HF hospitalization. To investigate this in an efficient and pragmatic manner, a factorial randomized control trial design will be used that will simultaneously investigate two separate important food-related questions. The first factorial design question will evaluate the direct impact of two nutritional supplementation strategies on rehospitalizations and ED visits for HF. Specifically, those hospitalized for HF will be randomized at hospital discharge to either 90 days of healthy medically tailored full meals (MTM) (n=50) or 90 days of a weekly fresh produce box (n=50) or to a control arm (usual care receiving no food supplements with dietary education only) (N=50).

The second factorial intervention will determine whether food supplements can be used as an incentive to increase patient engagement in their own care (i.e., attending a follow-up clinic visit and filling their prescriptions). Specifically, participants receiving food supplementation will be randomized 1:1 to receive their food supplements (MTMs or produce box) in an unconditional or conditional fashion based on the participant successfully attending their clinic visits and filling their medication.

02

Conditions studied

  • Heart Failure

Keywords

  • Heart Failure
  • Produce
  • Medically Tailored Meals
  • Patient Participation
03

In context

Heart Failure

5,697 studies on the registry are indexed under Heart Failure; 1,219 are open to participants now.

This study's enrollment of 150 is above the median of 72 across 3,733 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University of Texas Southwestern Medical Center is the lead sponsor of 990 studies on the registry; 201 are open to participants now.

Of its 135 completed or terminated interventional studies of FDA-regulated products, 100 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults over 18 years age with a recent hospitalization for acute decompensated HF

Exclusion criteria

Exclusion Criteria:

  • Baseline hyperkalemia with K > 5.5 mEq/L or history of hyperkalemia requiring hospitalization for urgent treatment,
  • Receipt of a heart transplant or left ventricular assist device,
  • Use of inotropic therapy at hospital discharge,
  • Discharge to a skilled nursing facility or long-term care facility that provides prepared patient meals, comorbidity with expected survival \< 6 months, and
  • Inability to provide an address to receive produce shipments (including unhoused individuals or individuals residing in temporary housing shelters).
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    Medically Tailored Meals

    Season Health, our food intervention partner, will provide participants with weekly deliveries of twice daily prepared medically tailored meals (MTM; 14 total per week). Study participants will be able to select choices for these in conjunction with a dietician. The study team will work with Season Health to create customizations to allow for the incorporation of patient dietary preferences. Study team members will assist patients in setting up their Season Health accounts.

    Dietary Supplement: Medically Tailored Meals Delivered Conditionally · Dietary Supplement: Medically Tailored Meals Delivered Unconditionally

  • Experimental
    Fresh Produce

    We will work with Season Health, our food intervention partner to provide participants with weekly deliveries of a large box full of fresh produce and pantry staples. The study participants will be able to select choices for these from a large selection of health options in conjunction with a dietician. The study team will work with Season Health to create customizations to allow for the incorporation of patient dietary preferences. Study team members will assist patients in setting up their Season Health accounts.

    Dietary Supplement: Produce Boxes delivered Conditionally · Dietary Supplement: Produce Boxes Delivered Unconditionally

  • No intervention
    Control arm

    This control arm will receive dietary education only with usual heart failure care.

Interventions

  • Dietary supplementMedically Tailored Meals Delivered Conditionally

    Season Health, our food intervention partner, will provide participants with weekly deliveries of twice-daily prepared medically tailored meals (MTM). Participants will receive this supplement conditioned on continued participation and engagement in their healthcare, including attending all scheduled office visits and refilling prescription medications. If participants do not refill their prescriptions or do not attend their office visits, the shipments of medically tailored meals will be paused. These will be restarted when the participant's appointment is rescheduled or when the participant's prescription is refilled.

  • Dietary supplementMedically Tailored Meals Delivered Unconditionally

    Season Health, our food intervention partner, will provide participants with weekly deliveries of twice-daily prepared medically tailored meals (MTM). Participants will receive this supplement unconditionally for the entire study duration.

  • Dietary supplementProduce Boxes delivered Conditionally

    Season Health, our food intervention partner, will provide participants with weekly deliveries of fresh produce and pantry staples. Participants will receive this supplement conditioned on continued participation and engagement in their healthcare, including attending scheduled office visits and refilling prescription medications. If participants do not refill their prescriptions or do not attend their office visits, the shipments of medically tailored meals will be paused. These will be restarted when the participant's appointment is rescheduled or when the participant's prescription is refilled.

  • Dietary supplementProduce Boxes Delivered Unconditionally

    Season Health, our food intervention partner, will provide participants with weekly deliveries of fresh produce and pantry staples. Participants will receive this supplement unconditionally throughout the entire study period.

06

What researchers measure

Primary outcomes

  1. Number of participants with a readmission or emergency department visit for HF

    Total readmissions or visits to the emergency department for HF

    Time frame: 90 days

Secondary outcomes

  1. Hierarchical Composite Endpoint

    Win-ratio based endpoint with the following hierarchy: (1) mortality, (2) readmission or ED visit for HF (total), (3) ≥10 point improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ) - Clinical Summary Score (CSS). The KCCQ clinical summary score ranges from 0 to 100, where higher scores indicating better quality of life.

    Time frame: 90 days

  2. Between group change in Kansas City Cardiomyopathy Questionnaire - Clinical Summary Score

    The KCCQ clinical summary score ranges from 0 to 100, where higher scores indicating better quality of life.

    Time frame: The survey will be assessed at baseline and at 90 days at the conclusion of the study.

  3. Medication adherence

    Morisky Medication Adherence Score. Scores are summed from 0 to 8, with higher scores meaning better adherence.

    Time frame: 90 days

  4. Attendance to scheduled clinic appointments

    Percent from 0-100%, calculated by the number of attended visits divided by the number of scheduled visits after excluding cancelled visits (either cancelled by provider or participant)

    Time frame: 90 days

  5. Filling of outpatient medication prescription

    Percent from 0-100%, calculated by percent of new prescriptions filled at pharmacy divided by number of prescriptions sent to pharmacy by providers

    Time frame: 90 days

07

Study locations

1 site
  • UT Southwestern Medical Center
    Dallas, Texas 75235, United States
08

References and documents

Publications

  • Pandey A, Keshvani N, Coellar JD, Jain AK, Segar MW, Bustillo-Rubio M, Rizvi SK, Peterson ED. Food Supplementation in Patients Hospitalized for Heart Failure: A Randomized Clinical Trial. JAMA Cardiol. 2026 Jun 1;11(6):564-573. doi: 10.1001/jamacardio.2026.0435. PubMed 41949846 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06115369
Lead sponsor
University of Texas Southwestern Medical Center
Collaborators
American Heart Association
Responsible party
Ambarish Pandey (Associate Professor, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Nov 3, 2023
Start date
Apr 15, 2024
Primary completion
Oct 15, 2025
Completion
Oct 30, 2025
Last update
Nov 18, 2025

Study contacts

Ambarish Pandey
principal investigator · UT Southwestern

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion